Marinus Pharmaceuticals Stock Price and Value Analysis

Should you buy Marinus Pharmaceuticals stock? (NasdaqGM:MRNS). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Marinus Pharmaceuticals to reach your target.

Target type
AdvantagesDisadvantagesNeutral
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company pays no dividend.

Inside the MRNS Numbers

MRNS Price
(Marinus Pharmaceuticals stock price per share)
$0.00
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Drug Manufacturers - General stocks
[?] Free Cash Flow Jitter 31%

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Is Marinus Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Marinus Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Advertisement supports free stock analysis content.

Should You Buy MRNS Stock?

Does Marinus Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

We don't yet have enough financial history for Marinus Pharmaceuticals to produce a full worked example. Check back as more data becomes available, or see the current price and research links below.